In recent days, Invivyd announced that the U.S. FDA has cleared its Investigational New Drug application, allowing the REVOLUTION clinical program for VYD2311, a monoclonal antibody alternative to ...

Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener An announcement ...

Greylock Partners unveiled two new endeavors Tuesday: A $1 billion early-stage fund — its 17th — and Greylock Edge, a program to support founders developing ideas into companies with early revenue and ...

HAYWARD, Calif., September 02, 2025--(BUSINESS WIRE)--Arcus Biosciences (NYSE:RCUS) announced today that it will host an in-person and virtual Investor Event for analysts and investors on Monday, ...

EXCLUSIVE: Industry training platform Stage 32 has revealed the 11 finalists selected for its inaugural Empowering Women Script Competition, running in collaboration with production company Catalyst ...